1. Alarcon RA (1968) Fluorometric determination of acrolein and related compounds with m-aminophenol. Anal Chem 40:1704?1708
2. Allen LM, Creaven PJ, Nelson RL (1976) Studies on the human pharmacokinetics of isophosphamide (NSC-109724). Cancer Treatm Rep 60:451?458
3. Brock N (1976) Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds. Cancer Treatm Rep 60:301?308
4. Brock N, Hohorst HJ (1977) The problem of specificity and selectivity of alkylating cytostatics: studies on N-2-chloro-ethylamido-oxazaphosphorines. Z Krebsforsch 88:185?215
5. Brock N, Stekar J, Pohl J, Niemyer U, Scheffler G (1979) Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide, and sufosfamide. Arzneim Forsch 29:659?661